M2D Global Life Sciences
Private Company
Funding information not available
Overview
M2D Global Life Sciences is a US-based, private consulting firm founded in 2015, offering high-level expertise in drug safety, quality, and regulatory compliance. The company operates as a service provider rather than a product developer, leveraging a team of former regulators and industry executives to conduct gap assessments, lead remediation projects, and stand up critical functions for clients. Its core value proposition is de-risking the development and commercialization pathways for biopharma companies through hands-on, inspection-ready program management and process optimization. M2D Global positions itself as a trusted partner for navigating the heavily regulated life sciences environment.
Technology Platform
Service-based platform of regulatory and compliance consulting methodologies, including frameworks for pharmacovigilance system builds, gap assessments, quality system implementation, and inspection-readiness.
Opportunities
Risk Factors
Competitive Landscape
M2D Global competes in a fragmented market with large, full-service Contract Research Organizations (CROs), major management consulting firms, and numerous small boutique consultancies. Its differentiation is a premium, hands-on service model led by former regulators and industry executives, targeting clients who need deep expertise and assured compliance outcomes rather than just staffing.